ARCHIVES

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Edwards Takes A Parting Shot At Cancer Program; “Forward Plan” Calls For Emphasis On Prevention

January 17, 1975

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Groups Push for CMS Coverage for LDCT Lung Screening

October 3, 2014

UT Health Science Center dedicates new Children’s Cancer Research Institute.

March 12, 2004

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

IOM Report Recommends Solutions to Problem of Medication Errors.

July 28, 2006